Electronic cigarettes, or e-cigarettes, are a popular new tobacco product that have still largely unknown public and individual health effects. Since they were introduced, e-cigarettes have sparked controversy. Opponents of e-cigarettes argue that there are hidden health risks to e-cigarettes, not the least of which is nicotine addiction. Proponents claim that e-cigarettes remove most of the harmful cancer causing agents for those who want to experience the pleasure they associate with tobacco.
BioDelivery Sciences International Inc recently announced that the U.S. Food and Drug Administration had approved its opioid treatment for chronic pain. Belbuca is an opioid film patch and aims to treat patients with chronic pain who need round-the-clock treatment and for whom current alternatives do not suffice. Belbuca has the advantages of lower possibility for abuse and less chance of causing constipation. Physicians will be able to prescribe the medication for 6 months at a time rather than by the month.
Personal genome sequencing costs have fallen sharply over the last several years, and more individuals are taking advantage of genetic testing services to learn about their ancestry and what diseases they might be susceptible to. There are privacy risks, however, that consumers often ignore when sharing their genetic data with these services.